BioSpace News Archive

Press Releases

BioVersys Joins EU-Funded RespiriNTM Programme to Accelerate Development of Its Broad-Spectrum Drug Candidates Against NTM Pulmonary Diseases

October 22, 2024
·
8 min read
Press Releases

Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization

October 22, 2024
·
3 min read
Press Releases

HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure

October 22, 2024
·
4 min read
Press Releases

Seamless Therapeutics to Present New Data at ESGCT Demonstrating its Ability to Reprogram Large Serine Recombinases to Specific Target Sites in the Human Genome

October 22, 2024
·
4 min read
Press Releases

Ring Therapeutics Presents Preclinical Data on Anellogy™ Platform at the 31st Annual European Society of Gene & Cell Therapy Conference

October 22, 2024
·
3 min read
Press Releases

BioPorto is proud to have Nine of the top-ten best US Children’s hospitals as customers of NGAL

October 22, 2024
·
4 min read
Press Releases

Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress

October 22, 2024
·
5 min read
Press Releases

Epicrispr Biotechnologies Presents Data on Powerful Gene Reactivation with GEMS Epigenetic Editors at ESGCT

October 22, 2024
·
3 min read
Press Releases

Vivet Therapeutics Presents Three Posters on Cerebrotendinous Xanthomatosis Program and Novel AAV Gene Delivery Platform at European Society of Gene and Cell Therapy Annual Congress 2024

October 22, 2024
·
8 min read
Press Releases

Laverock Therapeutics to Present New Data on Programmable, Tunable, Stable and Specific Gene Silencing Platform at ESGCT

October 22, 2024
·
3 min read